PHATHOM PHARMACEUTICALS, INC. Increase (Decrease) in Interest Payable, Net
PHATHOM PHARMACEUTICALS, INC. (PHAT) reported Increase (Decrease) in Interest Payable, Net of -$396.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2026-07-30
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for the quarter ending 2026-06-30 was -$239.00K.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for the quarter ending 2026-03-31 was -$157.00K, a 270.65% decline year-over-year.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for the quarter ending 2025-12-31 was $68.00K, a 64.02% decline year-over-year.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for the quarter ending 2025-09-30 was $10.00K, a 89.69% decline year-over-year.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for fiscal 2025 was $121.00K, a 78.58% decline from fiscal 2024.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for fiscal 2024 was $565.00K, a 93.49% increase from fiscal 2023.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for fiscal 2023 was $292.00K, a 22.55% decline from fiscal 2022.
- PHATHOM PHARMACEUTICALS, INC. increase (decrease) in interest payable, net for fiscal 2022 was $377.00K, a 128.48% increase from fiscal 2021.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$396.00K 10-Q · filed 2026-07-30 | -$328.00K derived: sum of 3 quarters · filed 2026-07-30 | -$318.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$157.00K 10-Q · filed 2026-04-30 | -$89.00K derived: sum of 2 quarters · filed 2026-04-30 | -$79.00K derived: sum of 3 quarters · filed 2026-04-30 | -$128.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $78.00K derived: sum of 2 quarters · filed 2026-02-26 | $29.00K derived: sum of 3 quarters · filed 2026-07-30 | $121.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$39.00K derived: sum of 2 quarters · filed 2026-07-30 | $53.00K 10-Q · filed 2025-10-30 | $242.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $43.00K 10-Q · filed 2026-07-30 | $232.00K derived: sum of 3 quarters · filed 2026-07-30 | $329.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $92.00K 10-Q · filed 2026-04-30 | $281.00K derived: sum of 2 quarters · filed 2026-04-30 | $378.00K derived: sum of 3 quarters · filed 2026-04-30 | $496.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $286.00K derived: sum of 2 quarters · filed 2026-02-26 | $404.00K derived: sum of 3 quarters · filed 2026-02-26 | $565.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $215.00K derived: sum of 2 quarters · filed 2025-10-30 | $376.00K 10-Q · filed 2025-10-30 | $565.00K derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $279.00K 10-Q · filed 2025-08-07 | $468.00K derived: sum of 3 quarters · filed 2025-08-07 | $498.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $161.00K 10-Q · filed 2025-05-01 | $350.00K derived: sum of 2 quarters · filed 2025-05-01 | $380.00K derived: sum of 3 quarters · filed 2025-05-01 | $396.00K derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $219.00K derived: sum of 2 quarters · filed 2025-03-06 | $235.00K derived: sum of 3 quarters · filed 2025-03-06 | $292.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $46.00K derived: sum of 2 quarters · filed 2024-11-07 | $103.00K 10-Q · filed 2024-11-07 | $271.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $16.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-08 | $73.00K 10-Q · filed 2024-08-08 | $241.00K derived: sum of 3 quarters · filed 2024-08-08 | $362.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $57.00K 10-Q/A · filed 2024-06-14 | $225.00K derived: sum of 2 quarters · filed 2024-06-14 | $346.00K derived: sum of 3 quarters · filed 2024-06-14 | $430.00K derived: sum of 4 quarters · filed 2024-06-14 |
| 2022-12-31 | $168.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-06-14 | $289.00K derived: sum of 2 quarters · filed 2024-06-14 | $373.00K derived: sum of 3 quarters · filed 2024-06-14 | $377.00K 10-K/A · filed 2024-06-14 |
| 2022-09-30 | $121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $205.00K derived: sum of 2 quarters · filed 2023-11-09 | $209.00K 10-Q · filed 2023-11-09 | $472.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $88.00K 10-Q · filed 2023-08-10 | $351.00K derived: sum of 3 quarters · filed 2023-08-10 | $263.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $4.00K 10-Q · filed 2023-05-10 | $267.00K derived: sum of 2 quarters · filed 2023-05-10 | $179.00K derived: sum of 3 quarters · filed 2023-05-10 | $169.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $263.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-02-28 | $175.00K derived: sum of 2 quarters · filed 2023-02-28 | $165.00K derived: sum of 3 quarters · filed 2023-02-28 | $165.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | -$88.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-09 | -$98.00K derived: sum of 2 quarters · filed 2022-11-09 | -$98.00K 10-Q/A · filed 2022-11-09 | -$88.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$10.00K 10-Q · filed 2022-08-02 | $0.00 derived: sum of 3 quarters · filed 2022-08-02 | $0.00 derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $10.00K derived: sum of 2 quarters · filed 2022-05-10 | $10.00K derived: sum of 3 quarters · filed 2022-05-10 | $75.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $10.00K derived: sum of 2 quarters · filed 2022-03-01 | $75.00K derived: sum of 3 quarters · filed 2022-03-01 | $156.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $65.00K derived: sum of 2 quarters · filed 2021-11-08 | $146.00K 10-Q · filed 2021-11-08 | -$2.04M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $146.00K 10-Q · filed 2021-08-10 | -$2.04M derived: sum of 3 quarters · filed 2021-08-10 | -$679.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $81.00K 10-Q · filed 2021-05-11 | -$2.11M derived: sum of 2 quarters · filed 2021-05-11 | -$744.00K derived: sum of 3 quarters · filed 2021-05-11 | $226.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$825.00K derived: sum of 2 quarters · filed 2021-03-30 | $145.00K derived: sum of 3 quarters · filed 2021-03-30 | $156.00K 10-K · filed 2021-03-30 |
| 2019-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $2.34M derived: sum of 2 quarters · filed 2020-11-10 | $2.35M 10-Q · filed 2020-11-10 | $2.35M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $970.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $981.00K 10-Q · filed 2020-08-06 | $986.00K derived: sum of 3 quarters · filed 2020-08-06 | |
| 2019-03-31 | $11.00K 10-Q · filed 2020-05-12 | $16.00K derived: sum of 2 quarters · filed 2020-05-12 | ||
| 2018-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $13.00K 10-K · filed 2020-03-19 | ||
| 2018-09-30 | $8.00K 10-Q · filed 2019-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |